Board Member
Aldeyra Therapeutics, Inc. (ALDX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Todd C. Brady is recorded as CEO and Board Member at Aldeyra Therapeutics, Inc. (ALDX). The proxy statement of Aldeyra Therapeutics, Inc. reports total compensation of $4,704,179 for Todd C. Brady in fiscal 2025, including a base salary of $700,000. Disclosed compensation is on record for 8 fiscal years. Todd C. Brady has spoken on 10 earnings calls and 1 other investor event across 1 company, most recently for Aldeyra Therapeutics, Inc. on June 4, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2005-01-01–present
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2005-01-01–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aldeyra Therapeutics, Inc. (ALDX) | M.D., Ph.D. President and Chief Executive Officer | $700,000 | $4,704,179 |
| 2024 | Aldeyra Therapeutics, Inc. (ALDX) | M.D., Ph.D. President and Chief Executive Officer | $591,631 | $3,931,645 |
| 2023 | Aldeyra Therapeutics, Inc. (ALDX) | M.D., Ph.D. President and Chief Executive Officer | $581,170 | $3,684,651 |
| 2022 | Aldeyra Therapeutics, Inc. (ALDX) | M.D., Ph.D. President and Chief Executive Officer | $559,357 | $2,858,490 |
| 2021 | Aldeyra Therapeutics, Inc. (ALDX) | M.D., Ph.D. President and Chief Executive Officer | $547,097 | $3,455,670 |
| 2020 | Aldeyra Therapeutics, Inc. (ALDX) | M.D., Ph.D. President and Chief Executive Officer | $543,871 | $2,421,362 |
| 2019 | Aldeyra Therapeutics, Inc. (ALDX) | M.D., Ph.D. President and Chief Executive Officer | $523,000 | $4,141,261 |
| 2018 | Aldeyra Therapeutics, Inc. (ALDX) | M.D., Ph.D. President and Chief Executive Officer | $506,000 | $2,876,740 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
